Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heli Malm

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of the American Academy of Child and Adolescent Psychiatry|April 30, 2016
Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based StudyHeli Malm, Alan S Brown, Mika Gissler, et al.
American Journal of Obstetrics & Gynecology MFM|February 6, 2026
SSRI use during pregnancy and maternal depression - a nationwide birth cohort study on risks to the mother and the newbornHeli Malm, Alan S Brown, Keely Cheslack-Postava, et al.
Reproductive Toxicology (Elmsford, N.Y.)|March 23, 2023
Maternal SSRI use during pregnancy and offspring depression or anxiety disorders: A review of the literature and description of a study protocol for a register-based cohort studySubina Upadhyaya, Alan Brown, Keely Cheslack-Postava, et al.
The Journal of Clinical Psychiatry|December 11, 2012
Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary reportAdrienne Einarson, Kelly Smart, Thierry Vial, et al.
JAMA Psychiatry|October 13, 2016
Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in OffspringAlan S Brown, David Gyllenberg, Heli Malm, et al.
Journal of Clinical Pharmacology|December 17, 2011
Pregnancy outcome following exposure to topical retinoids: a multicenter prospective studyAlice Panchaud, Chantal Csajka, Paul Merlob, et al.
Journal of Clinical Psychopharmacology|April 2, 2015
Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective studyUrsula Winterfeld, Gil Klinger, Alice Panchaud, et al.
Reproductive Toxicology (Elmsford, N.Y.)|July 1, 2008
The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational studyCorinna Weber-Schoendorfer, Doreen Hannemann, Reinhard Meister, et al.
British Journal of Clinical Pharmacology|March 27, 2015
Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort studyCorinna Weber-Schoendorfer, Marc Oppermann, Evelin Wacker, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|September 12, 2007
Pregnancy outcome of women exposed to azathioprine during pregnancyLee Hilary Goldstein, Galit Dolinsky, Revital Greenberg, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of the American Academy of Child and Adolescent Psychiatry|April 30, 2016
Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based StudyHeli Malm, Alan S Brown, Mika Gissler, et al.
American Journal of Obstetrics & Gynecology MFM|February 6, 2026
SSRI use during pregnancy and maternal depression - a nationwide birth cohort study on risks to the mother and the newbornHeli Malm, Alan S Brown, Keely Cheslack-Postava, et al.
Reproductive Toxicology (Elmsford, N.Y.)|March 23, 2023
Maternal SSRI use during pregnancy and offspring depression or anxiety disorders: A review of the literature and description of a study protocol for a register-based cohort studySubina Upadhyaya, Alan Brown, Keely Cheslack-Postava, et al.
The Journal of Clinical Psychiatry|December 11, 2012
Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary reportAdrienne Einarson, Kelly Smart, Thierry Vial, et al.
JAMA Psychiatry|October 13, 2016
Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in OffspringAlan S Brown, David Gyllenberg, Heli Malm, et al.
Journal of Clinical Pharmacology|December 17, 2011
Pregnancy outcome following exposure to topical retinoids: a multicenter prospective studyAlice Panchaud, Chantal Csajka, Paul Merlob, et al.
Journal of Clinical Psychopharmacology|April 2, 2015
Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective studyUrsula Winterfeld, Gil Klinger, Alice Panchaud, et al.
Reproductive Toxicology (Elmsford, N.Y.)|July 1, 2008
The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational studyCorinna Weber-Schoendorfer, Doreen Hannemann, Reinhard Meister, et al.
British Journal of Clinical Pharmacology|March 27, 2015
Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort studyCorinna Weber-Schoendorfer, Marc Oppermann, Evelin Wacker, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|September 12, 2007
Pregnancy outcome of women exposed to azathioprine during pregnancyLee Hilary Goldstein, Galit Dolinsky, Revital Greenberg, et al.
Pageof 5